Injection of botulinum toxin type B for the treatment of otolaryngology patients with secondary treatment failure of botulinum toxin type A

被引：11
作者：
Guntinas-Lichius, O [1 ]
机构：
[1] Univ Cologne, Dept Otorhinolaryngol Head & Neck Surg, D-50924 Cologne, Germany
来源：
LARYNGOSCOPE | 2003年 / 113卷 / 04期
关键词：
D O I：
10.1097/00005537-200304000-00029
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：743 / 745
页数：3
相关论文
共 16 条
[1]   Botulinum toxin: Basic science and clinical uses in otolaryngology [J].
Blitzer, A ;
Sulica, L .
LARYNGOSCOPE, 2001, 111 (02) :218-226
[2]   Botulinum toxin therapy, immunologic resistance, and problems with available materials [J].
Borodic, G ;
Johnson, E ;
Goodnough, M ;
Schantz, E .
NEUROLOGY, 1996, 46 (01) :26-29
[3]   Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia [J].
Brashear, A ;
Lew, MF ;
Dykstra, DD ;
Comella, CL ;
Factor, SA ;
Rodnitzky, RL ;
Trosch, R ;
Singer, C ;
Brin, MF ;
Murray, JJ ;
Wallace, JD ;
Willmer-Hulme, A ;
Koller, M .
NEUROLOGY, 1999, 53 (07) :1439-1446
[4]  
Dressler D, 2002, NERVENARZT, V73, P194, DOI 10.1007/s00115-001-1239-2
[5]   Botulinum neurotoxin serotype C: A novel effective botulinum toxin therapy in human [J].
Eleopra, R ;
Tugnoli, V ;
Rossetto, O ;
Montecucco, C ;
DeGrandis, D .
NEUROSCIENCE LETTERS, 1997, 224 (02) :91-94
[6]   DEVELOPMENT OF RESISTANCE TO BOTULINUM TOXIN TYPE-A IN PATIENTS WITH TORTICOLLIS [J].
GREENE, P ;
FAHN, S ;
DIAMOND, B .
MOVEMENT DISORDERS, 1994, 9 (02) :213-217
[7]   USE OF BOTULINUM TOXIN TYPE-F INJECTIONS TO TREAT TORTICOLLIS IN PATIENTS WITH IMMUNITY TO BOTULINUM TOXIN TYPE-A [J].
GREENE, PE ;
FAHN, S .
MOVEMENT DISORDERS, 1993, 8 (04) :479-483
[8]  
HAMBLETON P, 1995, HDB BOTULINUM TOXIN, P16
[9]  
Jankovic J, 1988, Adv Neurol, V49, P467
[10]   Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency [J].
Kessler, KR ;
Skutta, M ;
Benecke, R .
JOURNAL OF NEUROLOGY, 1999, 246 (04) :265-274
12